The role of viral and cellular miRNAs in B-cell lymphomagenesis
病毒和细胞 miRNA 在 B 细胞淋巴瘤发生中的作用
基本信息
- 批准号:8634961
- 负责人:
- 金额:$ 10万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-01 至 2016-08-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS-Related Diffuse Large B-cell LymphomaAcquired Immunodeficiency SyndromeAcuteAddressAdultAdvisory CommitteesApoptosisApoptoticAutomobile DrivingAwardB Cell ProliferationB lymphoid malignancyB-Cell ActivationB-Cell LymphomasB-Cell NeoplasmB-LymphocytesBindingBioinformaticsBiologicalBiological AssayBiological ModelsBiologyCancer ModelCell SurvivalCellsClinicalCritiquesDNA Tumor VirusesDataDevelopmentEpithelialEpithelial CellsEpstein-Barr Virus InfectionsEventGene ExpressionGene Expression ProfileGene Expression RegulationGene TargetingGenesGoalsGrowthHodgkin DiseaseHomologous GeneHumanHuman Herpesvirus 4ImmunoprecipitationIn VitroIndividualInfectionInfectious MononucleosisLMP1LaboratoriesLeadLearningLibrariesLifeLife Cycle StagesLinkLuciferasesLymphomaLymphomagenesisLymphoproliferative DisordersMalignant NeoplasmsMalignant lymphoid neoplasmMediatingMentorsMessenger RNAMethodologyMicroRNAsModelingMolecularOncogenicOutcomePathogenesisPathway interactionsPatientsPhasePlayPopulationPoriferaProcessRegulationReporterResourcesRibonucleosidesRoleSequence HomologySignal PathwaySignal TransductionStagingTNFRSF5 geneTechniquesTimeTrainingViralViral PathogenesisViral ProteinsVirusVirus DiseasesWestern BlottingWritingcell transformationcellular targetingcomputerized toolscrosslinkdeep sequencingin vivoinfected B cellinhibitor/antagonistinsightlarge cell Diffuse non-Hodgkin&aposs lymphomalatent infectionlatent persistent infectionlymphoblastoid cell linemeetingsmembermultidisciplinarynew therapeutic targetprogramspublic health relevanceresearch studytumorigenesisuncontrolled B lymphocyte proliferationviral RNAvirology
项目摘要
Project Summary
At least one in six human cancers is linked to viral infection. A portion of these can be attributed to
Epstein-Barr virus (EBV), a ubiquitous DNA tumor virus associated with cancers such as Burkitt's, Hodgkin's,
and diffuse large B cell lymphomas. During infection, EBV expresses viral microRNAs (miRNAs), and recent
studies have demonstrated an important role for the EBV miRNAs as well as the cellular oncogenic miRNAs
upregulated by EBV infection in the B cell transformation process. Furthermore, several EBV miRNAs share
sequence homology with cellular miRNAs that are dysregulated in cancers and potentially, these viral miRNAs
can tie into and alter existing miRNA-regulated networks. The miRNA targets involved in transformation are
not yet defined, and thus, systemically identifying the genes regulated by miRNAs in EBV-infected cells is
essential to understanding their contributions to viral oncogenesis and their roles during the EBV life cycle.
Experiments outlined here combine state-of-the-art techniques from the multidisciplinary fields of miRNA
biology, virology, and bioinformatics to comprehensively interrogate the miRNA targetome and examine the
transcriptional landscape of EBV-infected B cells in order to extract critical genes and pathways influenced by
viral and cellular miRNAs. These studies will be carried out using an EBV-driven in vitro B cell transformation
model in addition to patient-derived EBV+ B cell tumors. To successfully carry out my studies, I require new
training in both EBV biology and bioinformatics, and have accordingly assembled a scientific advisory
committee to guide me in establishing and/or further developing several of the essential methodologies. The
K99/R00 award will provide me both resources and time for new training during the mentored phase in order to
learn fundamental de novo infection techniques and generate additional data and computational tools to be
used in my own laboratory during the independent phase. By integrating the miRNA targetome data,
transcriptome data, and phenotypic data generated through these experiments, I hope to elucidate the
mechanisms by which miRNAs, particularly EBV miRNAs, contribute to persistent viral infection and the
development of lymphoma.
Finally, since EBV expresses not only viral miRNAs but further alters expression of oncogenic cellular
miRNAs that have been linked to many cancers not associated with viral infection, these studies will potentially
provide important information that can be extended to other cancer models and provide insight into the overall
mechanisms governing miRNA-mediated gene regulation in cancers.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rebecca L Skalsky其他文献
Analysis of the miRNA targetome in EBV-infected B cells
- DOI:
10.1186/1750-9378-7-s1-o2 - 发表时间:
2012-04-19 - 期刊:
- 影响因子:2.800
- 作者:
Rebecca L Skalsky;David L Corcoran;Eva Gottwein;Christopher L Frank;Markus Hafner;Jeffrey D Nusbaum;Regina Feederle;Henri-Jacques Delecluse;Micah Luftig;Thomas Tuschl;Uwe Ohler;Bryan R Cullen - 通讯作者:
Bryan R Cullen
Rebecca L Skalsky的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rebecca L Skalsky', 18)}}的其他基金
Characterizing single cell states of activated and transformed B cells in rhesus macaque models
恒河猴模型中活化和转化 B 细胞的单细胞状态特征
- 批准号:
10665491 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Regulation of host miRNA activity by Epstein-Barr virus BHRF1
Epstein-Barr 病毒 BHRF1 对宿主 miRNA 活性的调节
- 批准号:
10170258 - 财政年份:2020
- 资助金额:
$ 10万 - 项目类别:
Regulation of host miRNA activity by Epstein-Barr virus BHRF1
Epstein-Barr 病毒 BHRF1 对宿主 miRNA 活性的调节
- 批准号:
10039435 - 财政年份:2020
- 资助金额:
$ 10万 - 项目类别:
microRNA Regulation of Gamma-herpesvirus Latency and Reactivation
microRNA 对 γ-疱疹病毒潜伏期和再激活的调节
- 批准号:
10532215 - 财政年份:2019
- 资助金额:
$ 10万 - 项目类别:
microRNA Regulation of Gamma-herpesvirus Latency and Reactivation
microRNA 对 γ-疱疹病毒潜伏期和再激活的调节
- 批准号:
10084264 - 财政年份:2019
- 资助金额:
$ 10万 - 项目类别:
microRNA Regulation of Gamma-herpesvirus Latency and Reactivation
microRNA 对 γ-疱疹病毒潜伏期和再激活的调节
- 批准号:
10319587 - 财政年份:2019
- 资助金额:
$ 10万 - 项目类别:
The Role of Viral and Cellular miRNAs in B-cell Lymphomagenesis
病毒和细胞 miRNA 在 B 细胞淋巴瘤发生中的作用
- 批准号:
9334358 - 财政年份:2014
- 资助金额:
$ 10万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 10万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 10万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 10万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 10万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 10万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 10万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 10万 - 项目类别:














{{item.name}}会员




